about
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...
Read More
2.89
0.05
(1.76%)
940.4K
XNAS Volume
High volume today
XNAS 07 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Boundless Bio Inc is on 12 Aug 2026 for the purpose of Boundless Bio Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..